Therapeutic approach to pain in neurodegenerative diseases: current evidence and perspectives

References

• Beiske AG, Loge JH, Rønningen A, et al. Pain in Parkinson’s disease: prevalence and characteristics. Pain. 2009;141:173–177.
   PubMed Web of Science ®Google Scholar
• Classification of chronic pain, second edition, IASP Task Force on Taxonomy. In: Merskey H, Bogduk N, editors. ©1994.Part III: pain terms, a current list with definitions and notes on usage. Seattle (WA): IASP Press; 1994. p. 209–214.
   Google Scholar
• Jensen TS, Baron R, Haanpää M, et al. A new definition of neuropathic pain. Pain. 2011;152:2204–2205.
   PubMed Web of Science ®Google Scholar
• Haanpää M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152:14–27.
   PubMed Web of Science ®Google Scholar
• Helme RD, Gibson SJ. The epidemiology of pain in elderly people. Clin Geriatr Med. 2001;17:417–431.
   PubMed Web of Science ®Google Scholar
• Scherder E, Herr K, Pickering G, et al. Lautenbacher S Pain in dementia. Pain. 2009;145:276–768.
   PubMed Web of Science ®Google Scholar
• Zwakhalen S, Koopman R, Geels P, et al. The prevalence of pain in nursing home residents with dementia measured using an observational pain scale. Eur J Pain. 2009;13(1):89–93.
   PubMed Web of Science ®Google Scholar
• Vant’hof CE, Zwakhalen SMG, Hamers JPH. [Interventions after diagnosing pain in nursing home residents with dementia: the pilot implementation of an observational pain scale (PACSLAC-D)]. Tijdschr Gerontol Geriatr. 2011;42:67–78.
   Google Scholar
• Miro J, Paredes S, Rull M, et al. Pain in older adults: a prevalence study in the Mediterranean region of Catalonia. Eur J Pain. 2007;11:83–92.
   PubMed Web of Science ®Google Scholar
• Grimby C, Fastbom J, Forsell Y, et al. Musculoskeletal pain and analgesic therapy in a very old population. Arch Ger Geriat. 1999;29:29–43.
   PubMed Web of Science ®Google Scholar
• Horn SD, Bender SA, Bergstrom N, et al. Description of the national pressure ulcer long-term care study. J Am Ger Soc. 2002;50:1816–1825.
   PubMed Web of Science ®Google Scholar
• Black BS, Finucane T, Baker A, et al. Health problems and correlates of pain in nursing home residents with advanced dementia. Alz Dis Ass Dis. 2006;20:283–290.
   PubMed Web of Science ®Google Scholar
• Barry HE, Parsons C, Passmore APC, et al. Exploring the prevalence of and factors associated with pain: a cross sectional study of community dwelling people with dementia. Health Soc Care Community. 2015. doi:10.1111/hsc.12204,2015.
   PubMed Web of Science ®Google Scholar
• Hunt KLJ, Covinsky E, Yaffe K, et al. Pain in community? Dwelling older adults with dementia: results from the national health and aging trends study. J Am Ger Soc. 2015;63(8):1503–1511.
   PubMed Web of Science ®Google Scholar
• Mäntyselkä P, Hartikainen S, Louhivuori-Laako K, et al. Effects of dementia on perceived daily pain in home-dwelling elderly people: a population-based study. Age Ageing. 2004;33(5):496–499.
   PubMed Web of Science ®Google Scholar
• Leehey MA. Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J Investig Med. 2009;57(8):830–836.
   PubMed Web of Science ®Google Scholar
• Soontarapornchai K, Maselli R, Fenton-Farrell G, et al. Abnormal nerve conduction features in fragile X premutation carriers. Arch Neurol. 2008;65:495–498.
   PubMedGoogle Scholar
• Leehey MA, Legg W, Tassone F, et al. Fibromyalgia in fragile X mental retardation 1 gene premutation carriers. Rheumatology. 2011;50(12):2233–2236.
   PubMed Web of Science ®Google Scholar
• Ford B. Pain in Parkinson’s disease. Mov Disord L. 2010;25(98):S103.
   Google Scholar
• Truini A, Frontoni M, Cruccu G. Parkinson’s disease related pain: a review of recent findings. J Neurol. 2013;260:330–334.
   PubMed Web of Science ®Google Scholar
• Ha AD, Jankovic J. Pain in Parkinson’s disease. Mov Disord. 2012;27:485–491.
   PubMed Web of Science ®Google Scholar
• Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord. 1991;6:119–126.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Leder S, Warner D, et al. Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991;41:1088–1091.
   PubMed Web of Science ®Google Scholar
• Charles PD, Adler CH, Stacy M, et al. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy). J Neurol. 2014;261:1309–1319.
   PubMed Web of Science ®Google Scholar
• Blackie JD, Lees AJ. Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry. 1990;53:640–643.
   PubMed Web of Science ®Google Scholar
• Lorentz IT, Subramaniam SS, Yiannikas C. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients. Mov Disord. 1991;6:145–150.
   PubMed Web of Science ®Google Scholar
• Kutvonen O, Dastidar P, Nurmikko T. Pain in spasmodic torticollis. Pain. 1997;69:279–286.
   PubMed Web of Science ®Google Scholar
• Perrotta A, Bolla M, Serrao M, et al. Enhanced temporal pain processing in multiple system atrophy. Neurosci Lett. 2013;555:203–208.
   PubMed Web of Science ®Google Scholar
• Tison F, Wenning GK, Volonte MA, et al. Pain in multiple system atrophy. J Neurol. 1996;243:153–156.
   PubMed Web of Science ®Google Scholar
• Colosimo C, Morgante L, Antonini A, et al. PRIAMO STUDY GROUP. Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol. 2010;257:5–14.
   PubMed Web of Science ®Google Scholar
• Kass-Iliyya L, Kobylecki C, McDonald KR, et al. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson’s disease. Brain Behav. 2015;5:e00320.
   Web of Science ®Google Scholar
• Stamelou M, Dohmann H, Brebermann J, et al. Clinical pain and experimental pain sensitivity in progressive supranuclear palsy. Parkinsonism Relat Disord. 2012;18:606–608.
   PubMed Web of Science ®Google Scholar
• De Tommaso M, Serpino C, Difruscolo O, et al. Nociceptive inputs transmission in Huntington’s disease: a study by laser evoked potentials. Acta Neurol Belg. 2011;111(11):33–30.
   PubMed Web of Science ®Google Scholar
• De Tommaso M, Franco G, Ricci K, et al. Sciruicchio V laser evoked potentials in early and presymptomatic Huntington’s disease. Behavioural Neurology. 2016;2016:1–8.
   Web of Science ®Google Scholar
• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688–1700.
   PubMed Web of Science ®Google Scholar
• Turner MR, Swash M. The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey. J Neurol Neurosurg Psychiatry. 2015;86(6):667–673.
   PubMed Web of Science ®Google Scholar
• Weis J, Katona I, Müller-Newen G, et al. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76(23):2024–2029.
   PubMed Web of Science ®Google Scholar
• Lamin ME, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurol. 2013;80:1590–1597.
   PubMed Web of Science ®Google Scholar
• Drake ME Jr. Chronic pain syndrome in amyotrophic lateral sclerosis. Arch Neurol. 1983;40(7):453–454.
   PubMedGoogle Scholar
• Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology. 1999;52(7):1434–1440.
   PubMed Web of Science ®Google Scholar
• Jensen MP, Abresch RT, Carte GT, et al. Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil. 2005;86(6):1155–1163.
   PubMed Web of Science ®Google Scholar
• Ho DT, Ruthazer R, Russell JA. Shoulder pain in amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2011;13(1):53–55.
   PubMedGoogle Scholar
• Chiò A, Canosa A, Gallo S, et al. Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol. 2012;19(4):551–555.
   PubMed Web of Science ®Google Scholar
• Pagnini F, Lunetta C, Banfi P, et al. Pain in amyotrophic lateral sclerosis: a psychological perspective. Neurol Sci. 2012;33(5):1193–1196.
   PubMed Web of Science ®Google Scholar
• Rivera I, Ajroud-Driss S, Casey P, et al. Prevalence and characteristics of pain in early and late stages of ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013;4(5–6):369–7.
   Web of Science ®Google Scholar
• De Benedittis G, Massei R, Nobili R. Pieri A The Italian pain questionnaire. Pain. 1988;33:53–62.
   PubMed Web of Science ®Google Scholar
• Wallace VC, Ellis CM, Burman R, et al. The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):520–527.
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1–2):29–36.
   PubMed Web of Science ®Google Scholar
• Moisset X, Cornut-Chauvinc C, Clavelou P, et al. Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study. Palliat Med. 2016;30(5):486–494. pii: 0269216315600332.
   PubMed Web of Science ®Google Scholar
• Pizzimenti A, Aragona M, Onesti E, et al. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol. 2013;28(2):115–119.
   PubMedGoogle Scholar
• Hanisch F, Skudlarek A, Berndt J, et al. Characteristics of pain in amyotrophic lateral sclerosis. Brain Behav. 2015;5(3):e00296.
   PubMed Web of Science ®Google Scholar
• Defrin R, Amanzio M, De Tommaso M, et al. Experimental pain processing in individuals with cognitive impairment: current state of the science. Pain. 2015;156(8):1396–1408.
   PubMed Web of Science ®Google Scholar
• Kunz M, Scharmann S, Hemmeter U, et al. The facial expression of pain in patients with dementia. Pain. 2007;133:221–228.
   PubMed Web of Science ®Google Scholar
• Kunz M, Mylius V, Scharmann S, et al. Influence of dementia on multiple components of pain. Eur J Pain. 2009;13:317–325.
   PubMed Web of Science ®Google Scholar
• Cole LJ, Farrell MJ, Duff EP, et al. Pain sensitivity and fMRI pain-related brain activity in Alzheimer’s disease. Brain. 2006;129:2957–3265.
   PubMed Web of Science ®Google Scholar
• Cole LJ, Gavrilescu M, Johnston LA, et al. The impact of Alzheimer’s disease on the functional connectivity between brain regions underlying pain perception. Eur J Pain. 2011;15:568–11.
   PubMed Web of Science ®Google Scholar
• Gibson SJ, Voukelatos X, Ames D, et al. An examination of pain perception and cerebral event-related potentials following carbon dioxide laser stimulation in patients with Alzheimer’s disease and age-matched control volunteers. Pain Res Manag. 2001;6:126–132.
   PubMedGoogle Scholar
• Yamamoto M, Kachi T, Igata A. Pain related somatosensory evoked potentials in dementia. J Neurol Scienc. 1996;137:117–119.
   PubMed Web of Science ®Google Scholar
• Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain. 2003;126(Pt 5):1079–1091.
   PubMed Web of Science ®Google Scholar
• Oosterman JM, Traxler J, Kunz M. The influence of executive functioning on facial and subjective pain responses in older adults. Behavioural Neurology. (2016;2016:1–9.
   Web of Science ®Google Scholar
• Kunz M, Mylius V, Schepelmann K, et al. Loss in executive functioning best explains changes in pain responsiveness in patients with dementia-related cognitive decline. Behavioural Neurology. 2015;2015:1–7.
   Web of Science ®Google Scholar
• Tinazzi M, Del Vesco C, Defazio G, et al. Abnormal processing of the nociceptive input in Parkinson’s disease: a study with CO2 laser evoked potentials. Pain. 2008;136:117–124.
   PubMed Web of Science ®Google Scholar
• Djaldetti R, Shifrin A, Rogowski Z, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology. 2004;62:2171–2175.
   PubMed Web of Science ®Google Scholar
• Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study. J Neurol Neurosurg Psychiatry. 2007;78:1140–1142.
   PubMed Web of Science ®Google Scholar
• Tinazzi M, Recchia S, Simonetto S, et al. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing. J Neurol Sci. 2009;276:153–158.
   PubMed Web of Science ®Google Scholar
• Tinazzi M, Recchia S, Simonetto S, et al. Muscular pain in Parkinson’s disease and nociceptive processing assessed with CO2 laser-evoked potentials. Mov Disord. 2010;25:213–220.
   PubMed Web of Science ®Google Scholar
• Mylius V, Engau I, Teepker M, et al. Pain sensitivity and descending inhibition of pain in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2009;80:24–28.
   PubMed Web of Science ®Google Scholar
• Zambito Marsala S, Tinazzi M, Vitaliani R, et al. Spontaneous pain, pain threshold, and pain tolerance in Parkinson’s disease. J Neurol. 2011;258:627–633.
   PubMed Web of Science ®Google Scholar
• Perrotta A, Sandrini G, Serrao M, et al. Facilitated temporal summation of pain at spinal level in Parkinson’s disease. Mov Disord. 2011;26:442–448.
   PubMed Web of Science ®Google Scholar
• Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson’s disease: a clinical and positron emission tomography study. Mov Disord. 2005;20:1557–1563.
   PubMed Web of Science ®Google Scholar
• Brefel-Courbon C, Ory-Magne F, Thalamas C, et al. Nociceptive brain activation in patients with neuropathic pain related to Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:548–552.
   PubMed Web of Science ®Google Scholar
• Silva EG, Viana MA, Quagliato EM. Pain in Parkinson’s disease: analysis of 50 cases in a clinic of movement disorders. Arq Neuropsiquiatr. 2008;66:26–29.
   PubMed Web of Science ®Google Scholar
• Nègre-Pagès L, Regragui W, Bouhassira D, et al. DoPaMiP Study Group. Chronic pain in Parkinson’s disease: the cross-sectional French DoPaMiP survey. Mov Disord. 2008;23:1361–1369.
   PubMed Web of Science ®Google Scholar
• Defazio G, Tinazzi M, Berardelli A. How pain arises in Parkinson’s disease? Europ J Neurol. 2013;20:1517–1523.
   PubMed Web of Science ®Google Scholar
• Nolano M, Provitera V, Estraneo A, et al. Sensory deficit in Parkinson’s disease: evidence of a cutaneous denervation. Brain. 2008;131:1903–1911.
   PubMed Web of Science ®Google Scholar
• Kass-Iliyya L, Javed S, Gosal D, et al. Small fiber neuropathy in Parkinson’s disease: A clinical, pathological and corneal confocal microscopy study. Parkinsonism Relat Disord. 2015;21:1454–1460.
   PubMed Web of Science ®Google Scholar
• Truini A, Biasiotta A, Onesti E, et al. Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS. J Neurol. 2015;262(4):1014–1018.
   PubMed Web of Science ®Google Scholar
• Rosenkranz K, Pesenti A, Paulus W, et al. Focal reduction of intracortical inhibition in the motor cortex by selective proprioceptive stimulation. Exp Brain Res. 2003;149:9–16.
   PubMed Web of Science ®Google Scholar
• Rosenkranz K, Rothwell JC. The effect of sensory input and attention on the sensorimotor organization of the hand area of the human motor cortex. J Physiol. 2004;561:307–320.
   PubMed Web of Science ®Google Scholar
• Simone IL, Tortelli R, Samarelli V, et al. Laser evoked potentials in amyotrophic lateral sclerosis. J Neurol Sci. 2010;288(1–2):106–111.
   PubMed Web of Science ®Google Scholar
• Hamada M, Hanajima R, Terao Y, et al. Median nerve somatosensory evoked potentials and their high-frequency oscillations in amyotrophic lateral sclerosis. Clin Neurophysiol. 2007;118:877–886.
   PubMed Web of Science ®Google Scholar
• Caress JB, Ciarlone SL, Sullivan EA, et al. Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve. 2016;53(4):513–517.
   PubMed Web of Science ®Google Scholar
• Roos E, Mariosa D, Ingre C, et al. Depression in amyotrophic lateral sclerosis. Neurology. 2016 Apr 22;86:2271–2277.
   PubMed Web of Science ®Google Scholar
• Achterberg WP, Pieper MJC, Van Dalen-Kok AH, et al. Pain management in patients with dementia. Clin Interv Aging. 2013;8:1471–1482.
   PubMed Web of Science ®Google Scholar
• Tan E, Jokanovic N, Koponen M, et al. Simon Bell Prevalence of analgesic use and pain in people with and without dementia or cognitive impairment in aged care facilities: a systematic review and meta-analysis. Cur Cin Pharm. 2015;10(3):194–203.
   PubMed Web of Science ®Google Scholar
• Haasum Y, Fastbom J, Fratiglioni L, et al. Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly. Drugs and Aging. 2011;28:283–293.
   PubMed Web of Science ®Google Scholar
• Lvheim H, Karlsson S, Gustafson Y. The use of central nervous system drugs and analgesics among very old people with and without dementia. Pharmacoepidemiol Drug Saf. 2008;17(9):912–918.
   PubMed Web of Science ®Google Scholar
• Jensen-Dahm C, Werner MU, Jensen TS, et al. Discrepancy between stimulus response and tolerance of pain in Alzheimer disease. Neurology. 2015;84(15):1575–1581.
   PubMed Web of Science ®Google Scholar
• Sandvik RK, Selbæk G, Seifert R, et al. Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial. European Journal of Pain. 2014;18(10):1490–1500.
   PubMed Web of Science ®Google Scholar
• Petrò E, Ruffini E, Cappuccio M, et al. Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study. Neuropsychiatr Dis Treat. 2016;12:559–569.
   PubMed Web of Science ®Google Scholar
• Jensen-Dahm C, Gasse C, Astrup A, et al. Frequent use of opioids in patients with dementia and nursing home residents: a study of the entire elderly population of Denmark. Alzheimer’s Dementia. 2015;11(6):691–699.
   PubMed Web of Science ®Google Scholar
• Barber JB, Gibson SJ. Treatment of chronic non-malignant pain in the elderly: safety considerations. Drug Saf. 2009;32:457–474.
   PubMed Web of Science ®Google Scholar
• Husebo BS, Ballard C, Sandvik R, et al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ. 2011;343:d4065.
   PubMed Web of Science ®Google Scholar
• Husebo BS, Ballard C, Cohen-Mansfield J, et al. The response of agitated behavior to pain management in persons with dementia. Am J Geriatr Psychiatry. 2014;22:708–717.
   PubMed Web of Science ®Google Scholar
• Wills P1, Claesson CB, Fratiglioni L, et al. Drug use by demented and non-demented elderly people. Age Ageing. 1997;26(5):383–391.
   PubMed Web of Science ®Google Scholar
• Reynolds KS, Hanson LC, DeVellis RF, et al. Disparities in pain management between cognitively intact and cognitively impaired nursing home residents. J Pain Symptom Manage. 2008;35(4):388–396.
   PubMed Web of Science ®Google Scholar
• Broen MPJ, Braaksma MM, Patijn J, et al. Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool. Mov Disord. 2012;27:480–484.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Chaudhuri KR, MartinezMartin P, et al. PANDA study group. Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson’s disease (PANDA): a double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2015;14(12):1161–1170.
   PubMed Web of Science ®Google Scholar
• Brefel-Courbon C, Grolleau S, Thalamas C, et al. Comparison of chronic analgesic drugs prevalence in Parkinson’s disease, otherchronic diseases and the general population. Pain. 2009;141:14–18.
   PubMed Web of Science ®Google Scholar
• Broetz D, Eichner M, Gasser T, et al. Radicula rand nonradicular back pain in Parkinson’s disease: a controlledstudy. Mov Disord. 2007;22:853–856.
   PubMed Web of Science ®Google Scholar
• Madeo G, Schirinzi T, Natoli S, et al. Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain. J Neurol. 2015;262(9):2164–2170.
   PubMed Web of Science ®Google Scholar
• Dellapina E, Ory-Magne F, Regragui W, et al. Effect of subthalamic deep brain stimulation on pain in Parkinson’s disease. Pain. 2012;153:2267–2273.
   PubMed Web of Science ®Google Scholar
• Hefter H, Benecke R, Erbguth F, et al. An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ Open. 2013;3(4):pii:e001853. doi:10.1136/bmjopen-2012-001853.
   PubMed Web of Science ®Google Scholar
• Charles PD, Manack Adams A, Davis T, et al. Neck pain and cervical dystonia: treatment outcomes from CD PROBE (Cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy. Pain Pract. 2016. doi:10.1111/papr.12408.
   PubMedGoogle Scholar
• Lee MA, Walker RW, Hildreth TJ, et al. A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage. 2006;32(5):462–469.
   PubMed Web of Science ®Google Scholar
• Brettschneider J1, Kurent J, Ludolph A. Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2013;6:CD005226.
   PubMed Web of Science ®Google Scholar
• Newrick PG, Langton-Hewer R. Motor neuron disease: canwe do better? A study of 42 patients. BMJ. 1984;289(6444):539–542.
   PubMed Web of Science ®Google Scholar
• Wu PY. The management of patients with advanced motor neuron disease. Zhonghua Yi Xue Za Zhi (Taipei). 1998 Mar;61(3):141–145.
   PubMedGoogle Scholar
• Ganzini L, Johnston WS, Silveira MJ. The final month of life in patients with ALS. Neurology. 2002;59(3):428–431.
   PubMed Web of Science ®Google Scholar
• Neudert C, Oliver D, Wasner M, et al. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248(7):612–616.
   PubMed Web of Science ®Google Scholar
• Oliver DJ, Campbell C, O’brien T, et al. Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(6):562–564.
   PubMed Web of Science ®Google Scholar
• Mitchell J, Borasio G. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031–2041.
   PubMed Web of Science ®Google Scholar
• Miller RG, Moore DH, Gelinas DF 2nd, et al. Western ALS Study Group. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology. 2001;56(7):843–848.
   PubMed Web of Science ®Google Scholar
• Weber M, Goldman B, Truniger S. Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial. J Neurol Neurosurg Psychiatry. 2010;81(10):1135–1140.
   PubMed Web of Science ®Google Scholar
• Bedlack RS1, Pastula DM, Hawes J, et al. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. Amyotroph Lateral Scler. 2009;10(4):210–215.
   PubMed Web of Science ®Google Scholar
• Borasio GD, Shaw PJ, Hardiman O, et al. European ALS Study Group Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(3):159–164.
   PubMed Web of Science ®Google Scholar
• Weiss MD, Macklin EA, Simmons Z, et al. Mexiletine ALS Study Group. A randomized trial of mexiletine in ALS: safety and effects on muscle cramps and progression. Neurology. 2016;86(16):1474–1481.
   PubMed Web of Science ®Google Scholar
• Amtmann D, Weydt P, Johnson KL, et al. Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2004;21:95–104.
   PubMedGoogle Scholar
• McClelland S, Bethoux FA, Boulis NM, et al. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief. Muscle Nerve. 2008;3(3):396–398.
   Web of Science ®Google Scholar
• Jenkins TM, Hollinger H, McDermott CJ. The evidence for symptomatic treatments in amyotrophic lateral sclerosis. Curr Opin Neurol. 2014;27(5):524–531.
   PubMed Web of Science ®Google Scholar
• Mayadev AS, Weiss MD, Jane Distad B, et al. The amyotrophic lateral sclerosis center: a model of multidisciplinary management. Phys Med Rehab Clin North Am. 2008;19:619–631.
   PubMed Web of Science ®Google Scholar
• Carter GT, Rosen BS. Marijuana in the management of amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2001;18:264–270.
   PubMedGoogle Scholar
• Savage SR1, Romero-Sandoval A2, Schatman M3, et al. Cannabis in pain treatment: clinical and research considerations. J Pain. 2016;17(6):654–668.
   PubMed Web of Science ®Google Scholar
• Kaur P, Muthuraman A, Kaur M. The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. ACS Chem Neurosci. 2015;6(4):508–521.
   PubMed Web of Science ®Google Scholar
• Bessaguet F, Magy L, Desmoulière A, et al. The therapeutic potential of renin angiotensin aldosterone system (RAAS) in chronic pain: from preclinical studies to clinical trials. Expert Rev Neurother. 2016;16(3):331–339.
   PubMed Web of Science ®Google Scholar
• Stephens HE1, Lehman E2, Raheja D1, et al. Pain in amyotrophic lateral sclerosis: patient and physician perspectives and practices. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1–2):21–29.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Rizos A, Trenkwalder C, et al. King’s Parkinson’s disease pain scale, the first scale for pain in PD: an international validation. Mov Disord. 2015;30(12):1623–1631.
   PubMed Web of Science ®Google Scholar